Trump's health chief intensifies attack on drug middlemen, suggests getting rid of rebates
June 12, 2018 at 13:32 PM EDT
Firms negotiate discounts, or rebates, down from the list price drugmakers set. Critics argue the practice inflates drug prices because it encourages manufacturers to set higher prices.
